171 related articles for article (PubMed ID: 373439)
1. Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer.
Love LJ; Schimpff SC; Hahn DM; Young VM; Standiford HC; Bender JF; Fortner CL; Wiernik PH
Am J Med; 1979 Apr; 66(4):603-10. PubMed ID: 373439
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients.
Klastersky J; Glauser MP; Schimpff SC; Zinner SH; Gaya H
Antimicrob Agents Chemother; 1986 Feb; 29(2):263-70. PubMed ID: 3521475
[TBL] [Abstract][Full Text] [Related]
3. Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients.
Wade JC; Schimpff SC; Newman KA; Fortner CL; Standiford HC; Wiernik PH
Am J Med; 1981 Dec; 71(6):983-90. PubMed ID: 6459027
[TBL] [Abstract][Full Text] [Related]
4. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
De Jongh CA; Wade JC; Schimpff SC; Newman KA; Finley RS; Salvatore PC; Moody MR; Standiford HC; Fortner CL; Wiernik PH
Am J Med; 1982 Jul; 73(1):89-96. PubMed ID: 6211981
[TBL] [Abstract][Full Text] [Related]
5. Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patients.
Meunier F; Snoeck R; Lagast H; Woussen F; Klastersky J
J Antimicrob Chemother; 1986 May; 17 Suppl C():195-201. PubMed ID: 3636334
[TBL] [Abstract][Full Text] [Related]
6. [Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
Brion JP; Bru JP; Michallet M; Corron B; Fauconnier J
Presse Med; 1988 Oct; 17(37):1964-7. PubMed ID: 2973597
[TBL] [Abstract][Full Text] [Related]
7. Ticarcillin in combination with cephalothin or gentamicin as empiric antibiotic therapy in granulocytopenic cancer patients.
Schimpff SC; Landesman S; Hahn DM; Standiford HC; Fortner CL; Young VM; Wiernik PH
Antimicrob Agents Chemother; 1976 Nov; 10(5):837-44. PubMed ID: 795372
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of amikacin and ticarcillin as empiric therapy in febrile neutropenic children with cancer.
Faden HS; Deshpande GN; Grossi M; Surgalla M; Ettinger LJ; Freeman AI
Med Pediatr Oncol; 1981; 9(5):501-9. PubMed ID: 7300805
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
Johnson DE; Thompson B
Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
[TBL] [Abstract][Full Text] [Related]
10. Controlled comparison of amikacin and gentamicin.
Smith CR; Baughman KL; Edwards CQ; Rogers JF; Lietman PS
N Engl J Med; 1977 Feb; 296(7):349-53. PubMed ID: 319355
[TBL] [Abstract][Full Text] [Related]
11. Moxalactam/amikacin versus ticarcillin/amikacin in granulocytopenic patients.
Verghese A; Berk SL
Am J Med; 1983 Jun; 74(6):1092. PubMed ID: 6222648
[No Abstract] [Full Text] [Related]
12. European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients.
Croydon E; Weerts D
Chemioterapia; 1987 Jun; 6(2 Suppl):405-7. PubMed ID: 3334585
[No Abstract] [Full Text] [Related]
13. A prospective randomized study comparing the efficacy of Timentin alone or in combination with amikacin in the treatment of febrile neutropenic patients.
Bru JP; Michallet M; Legrand C; Swierz P; Stahl JP; Leautet JB; Sotto JJ; Hollard D; Micoud M
J Antimicrob Chemother; 1986 May; 17 Suppl C():203-9. PubMed ID: 3636335
[TBL] [Abstract][Full Text] [Related]
14. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
[TBL] [Abstract][Full Text] [Related]
15. Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients.
Finley RS; Fortner CL; deJongh CA; Wade JC; Newman KA; Caplan E; Britten J; Wiernik PH; Schimpff SC
Antimicrob Agents Chemother; 1982 Aug; 22(2):193-7. PubMed ID: 6765414
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.
Shenep JL; Hughes WT; Roberson PK; Blankenship KR; Baker DK; Meyer WH; Gigliotti F; Sixbey JW; Santana VM; Feldman S
N Engl J Med; 1988 Oct; 319(16):1053-8. PubMed ID: 3050517
[TBL] [Abstract][Full Text] [Related]
17. In vitro models for the study of combination antibiotic therapy in neutropenic patients.
Zinner SH; Dudley M; Blaser J
Am J Med; 1986 Jun; 80(6B):156-60. PubMed ID: 3728526
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of ticarcillin plus tobramycin versus carbenicillin plus gentamicin for the treatment of serious infections due to gram-negative bacilli.
Parry MF; Neu HC
Am J Med; 1978 Jun; 64(6):961-6. PubMed ID: 247895
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of netilmicin-ticarcillin and tobramycin-ticarcillin in the treatment of serious systemic infections in elderly patients.
Jansen W; Schwarz A
Clin Ther; 1984; 7(1):112-20. PubMed ID: 6394127
[TBL] [Abstract][Full Text] [Related]
20. Prospective comparative study of efficacy and toxicity of netilmicin and amikacin.
Bock BV; Edelstein PH; Meyer RD
Antimicrob Agents Chemother; 1980 Feb; 17(2):217-25. PubMed ID: 6992711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
